插秧机作业面积测量远程监测系统软件设计——基于VisualBasic.NET 2010

为实现对插秧机作业区域自动识别和作业面积的自动测量,实时掌握跨区作业插秧机远程作业面积参量值,以VisualStudio平台上的VisualBasic.NET2010为开发环境,开发了一套高速插秧机跨区作业面积远程测量监测系统软件。该软件功能主要包括GPS定位轨迹及作业区域的识别、面积测量、数据通讯、数据显示和数据存贮。系统采用VisualBasic.NET2010语言进行开发,将远程跨区作业的插秧机面积测量监测数据经由GPRS网络进行无线传输到上位机,并采用SOCKET组件和ADO.NET技术实现系统数据通信,完成PC机与下位机之间数据的传输,对测量结果进行显示存储,同时通过系统误差分析完成系统的可行性判断。     

土壤残膜振动筛的研究现状综述

主要介绍筛面物料的运动规律和试验方法的研究现状,分析了几种现有的筛分装置的工作原理,研究了现有的振动筛结构及工作参数的优化方案。同时,基于现有的研究成果为残膜机械的研究工作提供几点建议。     

耕深电子测量和显示装置的设计与试验研究

提出了一种基于角度传感器自动测量农机具耕深的方法。以悬挂机构位置和提升臂转角的几何对应关系为基础,通过检测提升臂的转角变化,推导出耕深值与测量电压值之间的线性关系并换算得到实际耕深。相对于其他耕深检测方式,该方法具有集成度高、封装小、安装和维护方便的特点。安装在驾驶室里的显示模块可为使用者提供实时数据,有利于使用者及时调整耕深,以保证拖拉机翻耕的质量。     

基于模糊控制的水肥药一体化系统研究

为了提高目前水肥药一体化系统的自动化程度,设计了一种智能水肥药一体化系统;针对系统混肥精度不高的问题,设计了适用于营养液混合的模糊控制器,并利用Lab VIEW完成整个系统应用软件的开发。该系统不但能够实现独立灌溉、灌溉施肥一体化、灌溉施药一体化及水肥药一体化,而且还具备控制指令输入、系统工作监控和系统信息查询的功能。     

Improved development of somatic cell cloned bovine embryos by a mammary gland epithelia cells in vitro model

Previous studies have established a bovine mammary gland epithelia cells in vitro model by the adenovirus-mediated telomerase (hTERT-bMGEs). The present study was conducted to confirm whether hTERT-bMGEs were effective target cells to improve the efficiency of transgenic expression and somatic cell nuclear transfer (SCNT). To accomplish this, a mammary-specific vector encoding human lysozyme and green fluorescent protein was used to verify the transgenic efficiency of hTERT-bMGEs, and untreated bovine mammary gland epithelial cells (bMGEs) were used as a control group. The results showed that the hTERT-bMGEs group had much higher transgenic efficiency and protein expression than the bMGEs group. Furthermore, the nontransgenic and transgenic hTERT-bMGEs were used as donor cells to evaluate the efficiency of SCNT. There were no significant differences in rates of cleavage or blastocysts or hatched blastocysts of cloned embryos from nontransgenic hTERT-bMGEs at passage 18 and 28 groups (82.8% vs. 81.9%, 28.6% vs. 24.8%, 58.6% vs. 55.3%, respectively) and the transgenic group (80.8%, 26.5% and 53.4%); however, they were significantly higher than the bMGEs group (71.2%, 12.8% and 14.8%), (p < 0.05). We confirmed that hTERT-bMGEs could serve as effective target cells for improving development of somatic cell cloned cattle embryos.     

Nanoemulsion formulation of florfenicol improves bioavailability in pigs

Nanotechnology applications in medicine have seen a tremendous growth in the past decade and are being employed to enhance the stability and bioavailability of lipophilic substances, such as florfenicol. This study aimed to examine the pharmacokinetic properties of the formulated oil‐in‐water florfenicol‐loaded nanoemulsion (FF‐NE). FF‐NE and florfenicol control (Nuflor^®) were administered to the pigs at a dose of 20 mg/kg. Nanoemulsion formulation of florfenicol was highly influenced in vivo plasma profile. The in vivo absorption study in pigs indicated that C_max (14.54 μg/mL) was significantly higher in FF‐NE, 3.42 times higher than the marketed formulation. In comparison with the control group, the relative bioavailability of formulated nanoemulsion was up to 134.5%. Assessment of bioequivalence using log‐transformed data showed that the 90% confidence intervals (90% CI) of C_max and AUC_0–∞ were 2.48–4.60 and 1.21–1.72, respectively.     

日光温室分段智能屋脊通风效果研究

针对现有日光温室人工通风方式劳动强度大、室内气温分布不均匀等问题,在温室内安装2台或3台智能型屋脊通风设备对温室进行2段或3段智能通风,并在北京地区冬季日光温室与人工通风控制进行了对比。结果表明:在保温被揭开期间,当采用3段智能通风时,温室内空气温度最大值与最小值之差为(1.1±0.5)℃;而2段智能控制和人工控制分别为(2.3±1.1)℃和(3.8±1.3)℃。此外,应用该智能屋脊通风技术,还能将667m2均效益提高0.97万元。因此,智能型屋脊通风设备可显著改善温室内温度分布的均匀性,提高种植的经济收益。     

大孔吸附树脂纯化黄花柳花总黄酮工艺研究

以黄花柳花为试材,采用紫外分光光度法,选择5种不同型号的树脂进行静态吸附试验,筛选出对其吸附解吸效性能高的树脂,再通过动态吸附与解吸试验研究上样浓度、树脂上样量、洗脱剂及流速等条件对黄花柳花总黄酮纯化效果的影响,优化维药黄花柳花总黄酮的大孔树脂纯化工艺。结果表明:AB-8型大孔吸附树脂对黄花柳花总黄酮具有较好的吸附解吸效果,最佳纯化条件为黄花柳花待纯化液浓度为3.13g/L,调节上样液pH 4.2,上样量5.5mL/g,以1.0mL/min流速上样,依次用10BV蒸馏水淋洗,6BV 70%乙醇以2.0mL/min流速洗脱,得纯化液。经AB-8纯化后的黄花柳花总黄酮纯度达51.99%。AB-8型大孔吸附树脂能有效提高黄花柳花中总黄酮纯度,并符合中药有效部位研究要求。     

Inhibition of porcine circovirus type 1 and type 2 production in PK-15 cells by small interfering RNAs targeting the Rep gene

Porcine circovirus type 1 (PCV1) and type 2 (PCV2) are two genotypes of porcine circovirus. Both of them are presumed to be widespread in the swine population. Currently, there is no specific treatment for their infections. RNA interference (RNAi) is a sequence-specific RNA degradation mechanism mediated by small interfering RNA (siRNA), which represents a possible therapeutic application for the treatment of viral infections. In this study, three siRNA expression plasmids (pS-RepA, pS-RepB and pS-RepC) were generated to target three different coding regions of the Rep protein (Rep) of PCV. These siRNAs were used to inhibit PCV production in a porcine kidney cell line, PK-15 cells. Our results revealed that Rep gene expression was inhibited by pS-RepA, pS-RepB and pS-RepC to different degrees. Moreover, our study also showed that the production of PCV1 and PCV2 was reduced by these siRNAs. pS-RepC, which targets the middle region of Rep gene, proved to be the most efficient siRNA for inhibition of Rep expression and viral production. Taken together, our data suggest that RNAi could be investigated as a potential treatment for PCV infection.     

Evaluation of immunogenicity and protective efficacy of Actinobacillus pleuropneumoniae HB04C(-) mutant lacking a drug resistance marker in the pigs

Previously, we reported the construction and characterization of a genetically defined Actinobacillus pleuropneumoniae (A. pleuropneumoniae) apxIIC gene mutant, HB04C(-), which conferred protection to mice against infection with A. pleuropneumoniae. In this study, we further evaluated HB04C(-) for safety and its ability to elicit protective immunity in pigs. It was demonstrated that a dose of 2 x 10(8) CFU HB04C(-) was safe to the pigs via intranasal or intramuscular injection. Immunization with a dose of 2 x 10(8) HB04C(-) by both intranasal and intramuscular routine could yield equal protective efficacy and elicited significant protection against experiment challenge with homologous or heterologous serotypes of a virulent A. pleuropneumonia. Taken together, HB04C(-) might serve as a promising vaccine candidate against infection with A. pleuropneumoniae.